BSEZR2 Bioenergy LtdMinimalNeutral
Announced Fri, 15 May · 21:45 IST

MONITORING AGENCY REPORT FOR THE QUARTER ENDED 31ST MARCH, 2026

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹146.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-1.4+1.4+2.7-2.4+2.7-6.4-16.3-11.6
Up moveDown movePending
AI summary

Crisil Ratings Limited has submitted the quarterly monitoring report for ZR2 Bioenergy's preferential issue proceeds. The original issue size of Rs. 248.77 crore has been reduced to Rs. 122.40 crore after 75% of warrant subscription was forfeited due to non-exercise of conversion rights. Of the revised proceeds, Rs. 103.90 crore has been utilized, leaving Rs. 18.50 crore unutilized. The monitoring agency has flagged a qualification that the company deployed Rs. 18.50 crore in a short-term deposit with Sukhmehar Finance Private Limited (an NBFC), deviating from industry practice of using bank fixed deposits or low-risk mutual funds. Additionally, this deployment was not disclosed in the shareholder notice. The biorefinery acquisition and expansion costs were revised down from Rs. 180 crore to Rs. 79.35 crore, and working capital/GCP costs from Rs. 46.77 crore to Rs. 21.05 crore, reflecting the reduced capital base.

Likely market impact

The forfeiture of warrants and revision of issue proceeds reduces the capital available for the biorefinery expansion project, potentially impacting growth plans. The unutilized funds sitting with an NBFC, rather than safer instruments, represents elevated risk for shareholders. The deviation from disclosed deployment plans raises governance concerns.